The title of this book surprises with the term “Lyme borreliosis,” which is rarely used in publications from the United States. Nevertheless, the specific term Lyme borreliosis is justified because it names a disease caused by particular infectious organisms, Borrelia burgdorferi sensu lato, whereas the term “Lyme disease” described a disease without a known cause and is now applied to a broad spectrum of symptoms where the infectious agent is not demonstrable (ie, chronic Lyme disease). Subsequently, Lyme disease and Lyme borreliosis have gained a high degree of prominence. Therefore, a book that deals with all aspects of the disease on evidence-based grounds written by authors who are well established in the field of clinical Lyme borreliosis is very welcome. Lyme Borreliosis in Europe and North America consists of 12 chapters. All chapters are substantiated by a series of references. Chapter 1 introduces historical details and epidemiology. The discovery of the Lyme spirochetes also made a great impact in Europe where clinical manifestations such as erythema chronicum migrans, benign lymphadenosis cutis, acrodermatitis chronic atrophicans (ACA), and Garin-Bujadoux-Bannwarth syndrome had been described previously and are now known to form a nosological entity of borrelial origin. Chapter 2 deals with the diversity of spirochetes, tick ecology, tick maintenance hosts, and spirochete reservoir hosts. It describes how the complex ecology underpinning the circulation of the spirochetes in nature depends on factors that maintain both tick populations and the vertebrate reservoirs of B. burgdorferi sensu lato. In chapter 3, “Early Lyme Borreliosis,” the authors refreshingly reject the stages of Lyme borreliosis that do not correlate with clinical experience. The more flexible descriptive terminology is recommended— namely, early localized, early disseminated, and late disease. Erythema migrans, the most frequent manifestation of Lyme borreliosis, is described in its various appearances. These are illustrated by many photographs, also given in an insert for color representation. The primarily clinical diagnosis of erythema migrans consequently requires a broad understanding of the various clinical presentations and of the differential diagnoses. In chapter 4, “Lyme Carditis,” the problems with the specific diagnosis of cardiac manifestations are described. The authors recommend caution particularly in fatal outcomes because of the difficulty of excluding the role of comorbidity. Chapter 5, “Nervous System Lyme Borreliosis,” clearly describes an approach to diagnosis, lists the relevant findings in the cerebrospinal fluid, and presents the clinical spectrum of Lyme neuroborreliosis. Prognosis and outcome after treatment with adequate antibiotics are evaluated extremely well. In chapter 6, “Lyme Arthritis,” the possible pathophysiological processes that may lead to antibiotic-resistant Lyme arthritis are described. Because clinical presentation of Lyme arthritis is not different from other inflammatory arthritides, it should be considered within the differential diagnosis of any arthritic condition. Dosages and duration for treatment of Lyme arthritis are supported only by a small number of clinical trials. Borrelial lymphocytoma and ACA, discussed in chapter 7, are considered to be more or less restricted to Europe, and are extremely rare manifestations in North America. Coinfection with Anaplasma phagocytophilum or Babesia species (chapter 8) may occur and may result in a severe course of disease. Although such interactions are rarely observed, they should be taken into consideration if patients present with fever, chills, and severe headache. Chapters 9 and 10 deal with the direct and indirect detection of B. burgdorferi sensu lato in human disease. Success of cultivation is best from skin specimens of erythema migrans and ACA and from plasma blood samples of US patients with erythema migrans. Sensitivity of polymerase chain reaction is similar in these manifestations. Serodiagnosis offers a simpler way to collect samples, perform testing, and achieve results in a short period of time to detect specific antibodies. Two-tiered serology and performance characteristics of tests are described, and the implications for serodiagnosis of the heterogeneity of B. burgdorferi sensu lato in Europe, newer assays, and future directions are discussed. The reader will learn about the role and usage of laboratory results for diagnosing Lyme borreliosis, including the avoidance of misinterpretation. Chapter 11 on prognosis deals with shortand long-term outcomes. Observational studies suggest that the prognosis is excellent. The editor himself is the single author of the last chapter, “Prevention of Lyme Borreliosis.” It deals with all available aspects including prevention of exposure, control Clinical Infectious Diseases 2013;56(9):1360–1 © The Author 2013. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals. permissions@oup.com. DOI: 10.1093/cid/cit077